AMRX$19.384.11%-0.83
Amneal Pharmaceuticals Inc (AMRX)
Date: 2026-11-04 16:00O: 20.55H: 20.55L: 19.02C: 19.81Vol: 2.129M
Amneal Pharmaceuticals Inc stock is traded at $19.38, with a volume of 1,144,189. It is down -4.11% in the last 24 hours and down -4.53% over the past month. Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Previous Close:
$20.21
Open:
$20.55
24h Volume:
1,144,189
Relative Volume:
0.25
Market Cap:
$6.75B
Revenue:
$3.05B
Net Income/Loss:
$181.32M
P/E Ratio:
51.96
EPS:
$0.373
Net Cash Flow:
$186.11M
1W Performance:
-8.33%
1M Performance:
-4.53%
6M Performance:
+47.83%
1Y Performance:
+70.75%
1-Day Range:
$19.02$20.55
1-Week Range:
$19.50$21.68
52-Week Range:
$10.68$21.68
Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS
Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades
Amneal Pharmaceuticals Inc Stock (AMRX) Financials Data
Amneal Pharmaceuticals Inc Stock (AMRX) Insider Trading
- BUCHI J KEVINSep 11 '26Director
- Transaction
- Option Exercise
- Cost
- $14.45
- #Shares
- 20,445
- Value ($)
- 295,430
- #Shares Total
- 95,522
- Kiely JohnAug 13 '26Director
- Transaction
- Sale
- Cost
- $17.64
- #Shares
- 50,000
- Value ($)
- 882,000
- #Shares Total
- 210,252
- JOHN KIELYAug 13 '26Director
- Transaction
- Proposed Sale
- Cost
- $17.59
- #Shares
- 50,000
- Value ($)
- 879,714
- #Shares Total
- 0
- NIKITA SHAHAug 12 '26Officer
- Transaction
- Proposed Sale
- Cost
- $17.47
- #Shares
- 146,403
- Value ($)
- 2,556,975
- #Shares Total
- 0
- Shah NikitaAug 12 '26Executive Vice President
- Transaction
- Sale
- Cost
- $17.51
- #Shares
- 146,403
- Value ($)
- 2,563,517
- #Shares Total
- 253,390
- Daly Jason B.Aug 12 '26EVP, Chief Legal Officer
- Transaction
- Sale
- Cost
- $17.40
- #Shares
- 210,000
- Value ($)
- 3,654,000
- #Shares Total
- 35,171
- BUCHI J KEVINAug 11 '26Director
- Transaction
- Proposed Sale
- Cost
- $17.31
- #Shares
- 168,573
- Value ($)
- 2,917,998
- #Shares Total
- 0
- Daly Jason B.Aug 11 '26EVP, Chief Legal Officer
- Transaction
- Sale
- Cost
- $17.70
- #Shares
- 6,613
- Value ($)
- 117,050
- #Shares Total
- 245,171
- JASON DALYAug 11 '26OFFICER
- Transaction
- Proposed Sale
- Cost
- $17.36
- #Shares
- 210,000
- Value ($)
- 3,646,285
- #Shares Total
- 0
- Autor Deborah M.May 11 '26Director
- Transaction
- Sale
- Cost
- $12.94
- #Shares
- 34,819
- Value ($)
- 450,558
- #Shares Total
- 93,660
